====== Focal cortical dysplasia ======

{{rss>https://pubmed.ncbi.nlm.nih.gov/rss/search/1d1GIw6PmDzkQuDqbUSgRIRoDI5oUdJpaa_9VXXoP-eyUEpQXy/?limit=15&utm_campaign=pubmed-2&fc=20230624073320}}

Focal [[cortical dysplasia]] (FCD) was first described as a distinct neuropathological entity in [[1971]] by Taylor and colleagues. FCD is thought to be an embryological migration disorder and is thus considered a non-progressive, unchangeable disease throughout life
((Kuroda N, Fujimoto A, Enoki H, Arai Y, Okanishi T. A case of focal cortical
dysplasia type Ib atypically showing reversible intensity changes on magnetic
resonance imaging which could be affected by epileptic discharge activity. Childs
Nerv Syst. 2019 Feb 27. doi: 10.1007/s00381-019-04093-4. [Epub ahead of print]
PubMed PMID: 30810857.
)).

Focal [[cortical dysplasia]] is a [[malformation]] of [[cortical]] development, which is the most common cause of [[drug resistant epilepsy]] in the pediatric population
((Kabat J, Król P. Focal cortical dysplasia - review. Pol J Radiol. 2012
Apr;77(2):35-43. PubMed PMID: 22844307; PubMed Central PMCID: PMC3403799.
)).

===== Epidemiology =====

see [[Focal cortical dysplasia epidemiology]].

===== Classification =====

see [[Focal cortical dysplasia classification]].

===== Pathogenesis =====

[[Focal cortical dysplasia pathogenesis]]


===== Diagnosis =====

see [[Focal cortical dysplasia diagnosis]].
===== Treatment =====

see [[Focal cortical dysplasia treatment]].

===== Outcome =====

see [[Focal cortical dysplasia outcome]].

===== Case series =====

see [[Focal cortical dysplasia case series]].

===== Case reports =====

[[Focal cortical dysplasia case reports]].